{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:25:36Z","timestamp":1779128736657,"version":"3.51.4"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100021136","name":"Indian Institute of Technology Hyderabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021136","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Acute myeloid leukemia (AML) is one of the leading leukemic malignancies in adults. The heterogeneity of the disease makes the diagnosis and treatment extremely difficult. With the advent of next-generation sequencing (NGS) technologies, exploration at the molecular level for the identification of biomarkers and drug targets has been the focus for the researchers to come up with novel therapies for better prognosis and survival outcomes of AML patients. However, the huge amount of data from NGS platforms requires a comprehensive AML platform to streamline literature mining efforts and save time. To facilitate this, we developed AMLdb, an interactive multi-omics platform that allows users to query, visualize, retrieve, and analyse AML related multi-omics data. AMLdb contains 86 datasets for gene expression profiles, 15 datasets for methylation profiles, CRISPR-Cas9 knockout screens of 26 AML cell lines, sensitivity of 26 AML cell lines to 288 drugs, mutations in 41 unique genes in 23 AML cell lines, and information on 41 experimentally validated biomarkers. In this study, we have reported five genes, i.e. CBFB, ENO1, IMPDH2, SEPHS2, and MYH9 identified via our analysis using AMLdb. ENO1 is uniquely identified gene which requires further investigation as a novel potential target while other reported genes have been previously confirmed as targets through experimental studies. Top of form we believe that these findings utilizing AMLdb can make it an invaluable resource to accelerate the development of effective therapies for AML and assisting the research community in advancing their understanding of AML pathogenesis. AMLdb is freely available at https:\/\/project.iith.ac.in\/cgntlab\/amldb.<\/jats:p>","DOI":"10.1093\/bfgp\/elae024","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T11:05:18Z","timestamp":1718190318000},"page":"798-805","source":"Crossref","is-referenced-by-count":3,"title":["AMLdb: a comprehensive multi-omics platform to identify biomarkers and drug targets for acute myeloid leukemia"],"prefix":"10.1093","volume":"23","author":[{"given":"Keerthana","family":"Vinod Kumar","sequence":"first","affiliation":[{"name":"Department of Biotechnology, Indian Institute of Technology Hyderabad , Kandi, Telangana 502284 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambuj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Indian Institute of Technology Hyderabad , Kandi, Telangana 502284 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Kundal","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Indian Institute of Technology Hyderabad , Kandi, Telangana 502284 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avik","family":"Sengupta","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Indian Institute of Technology Hyderabad , Kandi, Telangana 502284 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunjulakshmi","family":"R","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Indian Institute of Technology Hyderabad , Kandi, Telangana 502284 ,","place":["India"]},{"name":"Department of Biological Sciences, Indian Institute of Science Education and Research , Berhampur, Odisha 760010 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subashani","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Indian Institute of Technology Hyderabad , Kandi, Telangana 502284 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhanu Teja","family":"Korra","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Indian Institute of Technology Hyderabad , Kandi, Telangana 502284 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simran","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Indian Institute of Technology Hyderabad , Kandi, Telangana 502284 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vandana","family":"Suresh","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Indian Institute of Technology Hyderabad , Kandi, Telangana 502284 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayilaadumveettil","family":"Nishana","sequence":"additional","affiliation":[{"name":"School of Biology, Indian Institute of Science Education and Research , Thiruvananthapuram, Maruthamala P. O., Vithura, Kerala 695551 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6927-5390","authenticated-orcid":false,"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Indian Institute of Technology Hyderabad , Kandi, Telangana 502284 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"2024121023134550400_ref1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.hoc.2009.11.008","article-title":"Acute myeloid Leukemia","volume":"24","author":"Rubnitz","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"key":"2024121023134550400_ref2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/ajh.25214","article-title":"Acute myeloid leukemia: 2019 update on risk-stratification and management","volume":"93","author":"Estey","year":"2018","journal-title":"Am J Hematol [Internet]"},{"key":"2024121023134550400_ref3","first-page":"EPR22","article-title":"EPR22-104: a comparison of the burden of Leukemia amongst various regions of the world, 1990-2019","volume":"20","author":"Ahmed","year":"2022","journal-title":"J Natl Compr Cancer Netw [Internet]"},{"key":"2024121023134550400_ref4","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J [Internet]"},{"key":"2024121023134550400_ref5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood-2015-01-621664","article-title":"International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with &gt;30% blasts","volume":"126","author":"Dombret","year":"2015","journal-title":"Blood [Internet]"},{"key":"2024121023134550400_ref6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajh.24246","article-title":"Acute myeloid leukemia\u2014major progress over four decades and glimpses into the future","volume":"91","author":"Kantarjian","year":"2016","journal-title":"Am J Hematol [Internet]"},{"key":"2024121023134550400_ref7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"New Engl J Med [Internet]"},{"key":"2024121023134550400_ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40291-019-00443-9","article-title":"Clinical utility of next-generation sequencing in acute myeloid leukemia","volume":"24","author":"Yang","year":"2020","journal-title":"Mol Diagn Ther [Internet]"},{"key":"2024121023134550400_ref9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"key":"2024121023134550400_ref10","article-title":"International Cancer Genome Consortium Data portal--a one-stop shop for cancer genomics data","author":"Zhang","journal-title":"Database (Oxford),"},{"key":"2024121023134550400_ref11","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","journal-title":"Nucleic Acids Research,"},{"key":"2024121023134550400_ref12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMp1607591","article-title":"Toward a shared vision for cancer genomic data","volume":"375","author":"Grossman","year":"2016","journal-title":"N Engl J Med [Internet]"},{"key":"2024121023134550400_ref13"},{"key":"2024121023134550400_ref14","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","journal-title":"Nucleic Acids Research,"},{"key":"2024121023134550400_ref15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","article-title":"The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website","volume":"91","author":"Bamford","year":"2004","journal-title":"Br J Cancer"},{"key":"2024121023134550400_ref16"},{"key":"2024121023134550400_ref17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tig.2013.05.010","article-title":"Human housekeeping genes, revisited","volume":"29","author":"Eisenberg","year":"2013","journal-title":"Trends Genet"},{"key":"2024121023134550400_ref18","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1182\/blood-2022-169475","article-title":"CBFB-MYH11 is required for the maintenance of Inv(16) AML","volume":"140","author":"Panda","year":"2022","journal-title":"Blood N Y"},{"key":"2024121023134550400_ref19","doi-asserted-by":"crossref","first-page":"e15631","DOI":"10.15252\/emmm.202115631","article-title":"IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia","volume":"15","author":"Liu","year":"2023","journal-title":"EMBO Mol Med [Internet]"},{"key":"2024121023134550400_ref20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.stem.2022.01.003","article-title":"An oncogenic enhancer encodes selective selenium dependency in AML","volume":"29","author":"Eagle","year":"2022","journal-title":"Cell Stem Cell [Internet]"},{"key":"2024121023134550400_ref21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.18632\/oncotarget.10613","article-title":"Prognostic impact of MYH9 expression on patients with acute myeloid leukemia","volume":"8","author":"Yu","year":"2016","journal-title":"Oncotarget [Internet]"}],"container-title":["Briefings in Functional Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bfg\/article-pdf\/23\/6\/798\/60974297\/elae024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bfg\/article-pdf\/23\/6\/798\/60974297\/elae024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T23:14:42Z","timestamp":1733872482000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bfg\/article\/23\/6\/798\/7691499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,12]]},"published-print":{"date-parts":[[2024,12,6]]}},"URL":"https:\/\/doi.org\/10.1093\/bfgp\/elae024","relation":{},"ISSN":["2041-2649","2041-2657"],"issn-type":[{"value":"2041-2649","type":"print"},{"value":"2041-2657","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,6,12]]}}}